Registering Diagnostic and Prognostic Trials of Tests: Is It the Right Thing to Do?

Nader Rifai; Patrick M. M. Bossuyt; John P. A. Ioannidis; Kurtis R. Bray; Lisa M. McShane; Robert M. Golub; Lotty Hooft

doi:https://doi.org/10.1373/clinchem.2014.226100

Registering Diagnostic and Prognostic Trials of Tests: Is It the Right Thing to Do?

Nader Rifai, Patrick M. M. Bossuyt, John P. A. Ioannidis, Kurtis R. Bray, Lisa M. McShane, Robert M. Golub, Lotty Hooft

Research output: Contribution to journal › Editorial › Academic › peer-review

18 Citations (Scopus)

Original language	English
Pages (from-to)	1146-1152
Journal	Clinical Chemistry
Volume	60
Issue number	9
DOIs	https://doi.org/10.1373/clinchem.2014.226100
Publication status	Published - 2014

Access to Document

https://doi.org/10.1373/clinchem.2014.226100

Cite this

@article{c928a9b471694c2c92093c1a600ce781,

title = "Registering Diagnostic and Prognostic Trials of Tests: Is It the Right Thing to Do?",

author = "Nader Rifai and Bossuyt, {Patrick M. M.} and Ioannidis, {John P. A.} and Bray, {Kurtis R.} and McShane, {Lisa M.} and Golub, {Robert M.} and Lotty Hooft",

year = "2014",

doi = "https://doi.org/10.1373/clinchem.2014.226100",

language = "English",

volume = "60",

pages = "1146--1152",

journal = "Clinical Chemistry",

issn = "0009-9147",